Dotchin & Associates on Behalf of Emergent Biosolutions
Global life sciences company
Based in MD
AI Overview
With $0 in lobbying spend across 9 quarterly filings, Dotchin & Associates on Behalf of Emergent Biosolutions is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2020 to 2021.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $0 |
| 2021 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Disaster Planning, Budget/Appropriations, Homeland Security, Defense
FY 2021 appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures for the US government. National Defense Authorization Act
COVID 19 provisions
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.